The dose of 1,25-dihydroxyvitamin D3 (calcitriol or VD), a promising therapeutic agent for gastric cancer, is limited by hypercalcemia if administered systemically. Here we explored the feasibility of applying fibrin matrix as high-dose VD carrier for topical application. Our results indicated that VD did not significantly alter the morphological, rheological and degradation characteristics of fibrin matrix except decreasing gelation time by its solvent DMSO. Furthermore, VD could be sustainably released from fibrin for more than 96 hours. Most importantly, fibrin containing high-dose VD increased gastric cancer cells apoptosis in contrast to VD alone of the same concentration, which might be due to the synergistic effects of sustained release of VD and D-dimer, the degradation products of fibrin. This study suggests that local delivery of high-dose calcitriol carried by fibrin matrix might be a promising adjuvant therapy for gastric cancer surgery.
TorreLASiegelRLWardEM, et al.
Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev2016;
25: 16–27.
2.
CatsAJansenEPvan GriekenNC, et al.
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol2018;
19: 616–628.
3.
BersanelliMLeonettiAButiS.The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockade. Future Med2017;
2017: 1127–1131.
4.
KeLMasonRSBaurLA, et al.
Vitamin D levels in childhood and adolescence and cardiovascular risk factors in a cohort of healthy Australian children. J Steroid Biochem Mol Biol2018;
177: 270–277.
5.
MansonJECookNRLeeI-M, et al.
Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med2019;
380: 33–44.
6.
PengWWangKZhengR, et al.
1, 25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest. Endocr Res2016;
41: 71–80.
7.
JeongYSwamiSKrishnanAV, et al.
Inhibition of mouse breast tumor initiating cells by calcitriol and dietary vitamin D. Mol Cancer Ther2015;
14: 1951–1961.
8.
Ferrer-MayorgaGLarribaMJCrespoP, et al.
Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol2019;
185: 1–6.
9.
RodriguezGCTurbovJRosalesR, et al.
Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: an opportunity for chemoprevention. Gynecol Oncol2016;
143: 159–167.
10.
LiMLiLZhangL, et al.
1, 25-Dihydroxyvitamin D3 suppresses gastric cancer cell growth through VDR-and mutant p53-mediated induction of p21. Life Sci2017;
179: 88–97.
11.
CakiciCYigitbasiTAylaS, et al.
Dose-dependent effects of vitamin 1, 25 (OH) 2D3 on oxidative stress and apoptosis. J Basic Clin Physiol Pharmacol2018;
29: 271–279.
12.
ShimizuTKamelWAYamaguchi, et al.
Calcitriol exerts an anti‐tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response. Cancer Sci2017;
108: 1793–1802.
13.
KlopotowskaDMatuszykJWietrzykJ.Steroid hormone calcitriol and its analog tacalcitol inhibit miR-125b expression in a human breast cancer MCF-7 cell line. Steroids2018;
141: 70–75.
14.
NicolasSBolzingerM-AJordheimLP, et al.
Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells. Int J Pharm2018;
550: 170–179.
15.
ChenQZhangZLiuJ, et al.
A fibrin matrix promotes the differentiation of EMSCs isolated from nasal respiratory mucosa to myelinating phenotypical Schwann-like cells. Mol Cells2015;
38: 221–228.
16.
ZhangZHeQDengW, et al.
Nasal ectomesenchymal stem cells: multi-lineage differentiation and transformation effects on fibrin gels. Biomaterials2015;
49: 57–67.
17.
VialeMMonticoneMMaricI, et al.
Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations. Pharmacol Rep2018;
70: 760–765.
18.
BreenAO'BrienTPanditA.Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B: Rev2009;
15: 201–214.
19.
TredwellSJacksonJKHamiltonD, et al.
Use of fibrin sealants for the localized, controlled release of cefazolin. Can J Surg2006;
49: 347–352.
20.
AnaiSHideTTakezakiT, et al.
Antitumor effect of fibrin glue containing temozolomide against malignant glioma. Cancer Sci2014;
105: 583–591.
21.
TajdaranKShoichetMSGordonT, et al.
A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). Biotechnol Bioeng2015;
112: 1948–1953.
22.
EyrichDBrandlFAppelB, et al.
Long-term stable fibrin gels for cartilage engineering. Biomaterials2007;
28: 55–65.
23.
ZhouWZhaoMZhaoY, et al.
A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies. J Mater Sci: Mater Med2011;
22: 1221–1230.
24.
HolbroAGrafLTopalidouM, et al.
Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment. Transfusion2014;
54: 1508–1514.
25.
SpicerPPMikosAG.Fibrin glue as a drug delivery system. J Control Release2010;
148: 49–55.
26.
WangWZhaoC-HZhangN, et al.
Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway. Nutr Cancer2013;
65: 1067–1075.
27.
ChangSGaoLYangY, et al.
miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells. Oncotarget2015;
6: 7675–7685.
28.
Segovia-MendozaMDíazLPrado-GarciaH, et al.
The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells. Am J Cancer Res2017;
7: 1486–1500.
29.
Ben-EltrikiMDebSAdomatH, et al.
Calcitriol and 20 (S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells. J Steroid Biochem Mol Biol2016;
158: 207–219.
30.
BluttSEMcDonnellTJPolekTC, et al.
Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology2000;
141: 10–17.
31.
YangJLiuXBhallaK, et al.
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science1997;
275: 1129–1132.
32.
MaramponFGravinaGFestucciaC, et al.
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis. J Endocrinol Invest2016;
39: 411–422.
33.
YaoTYingXZhaoY, et al.
Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy. Antioxidants & Redox Signal2015;
22: 633–650.
34.
SergeevINSongQ.High vitamin D and calcium intakes reduce diet‐induced obesity in mice by increasing adipose tissue apoptosis. Mol Nutr Food Res2014;
58: 1342–1348.
35.
MathiasenISLademannUJäätteläM.Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res1999;
59: 4848–4856.
36.
NarvaezCJWelshJ.Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem2001;
276: 9101–9107.
37.
PetkovichMMelnickJWhiteJ, et al.
Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. J Steroid Biochem Mol Biol2015;
148: 283–289.
38.
SunHJiangCCongL, et al.
CYP24A1 Inhibition facilitates the antiproliferative effect of 1, 25 (OH) 2D3 through downregulation of the WNT/β-Catenin pathway and methylation-mediated regulation of CYP24A1 in colorectal cancer cells. DNA Cell Biol2018;
37: 742–749.
39.
BellamyVVanneauxVBelA, et al.
Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold. J Heart Lung Transplant2015;
34: 1198–1207.
40.
Di MiccoPRomanoMNiglioA, et al.
Alteration of haemostasis in non-metastatic gastric cancer. Dig Liver Dis2001;
33: 546–550.
41.
DiaoDChengYSongY, et al.
D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer. BMC Cancer2017;
17: 56–64.
42.
LiuLZhangXYanB, et al.
Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients. PLoS One2014;
9: e90547
43.
WatanabeAArakiKHarimotoN, et al.
D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer. Int J Clin Oncol2018;
23: 689–697.
44.
BiniAWuDSchnuerJ, et al.
Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin (ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. Biochemistry1999;
38: 13928–13935.
